Human Menopausal Gonadotropin:
What is HMG?
Human Menopausal Gonadotropin (HMG) combines two essential reproductive hormones—follicle-stimulating hormone (FSH) and luteinizing hormone (LH)—derived from human urine. Scientists use HMG in research to study how these hormones regulate fertility, promote egg development, support testosterone production, and control reproductive hormones. In laboratory environments, HMG works by attaching to specific cellular receptors that manage reproduction, hormone production, and the body's hormone-regulating feedback systems.
Research Uses
Studying Egg Development
HMG helps researchers understand how eggs grow and mature. When HMG is added to ovarian cells in the lab, it makes cells multiply and produce estrogen. Scientists measure how many cells grow and how much estrogen is made, allowing them to understand the normal egg development process better.
Supporting Sperm Production
In male reproductive research, HMG stimulates cells that produce testosterone and support sperm development. Researchers measure testosterone levels and count developing sperm cells to see how well HMG works in supporting male fertility functions.
Understanding Hormone Control
HMG research reveals how the brain's pituitary gland communicates with reproductive tissues through hormones. Studies show how this system maintains balance through feedback loops—when hormone levels are high, the system produces less, and when they drop, the system produces more. This keeps reproduction working properly.
Fertility Treatment Research
Scientists test HMG dosing strategies to help develop better fertility treatments. Research shows how HMG can stimulate the growth of multiple eggs at once and coordinate hormone timing, improving success rates for fertility procedures.
Product Specifications
What We Know About This HMG Batch
This HMG product comes from purified human urine containing two different hormone types. Because hormones naturally vary slightly, we cannot specify one exact molecular weight, but testing shows consistent quality.
Molecular Weight: 711.9 Da Purity: 99.42% Batch Number: 2025007 Analysis Method: Mass spectrometry and liquid chromatography Quality Check: Primary hormone confirmed; trace impurity at 0.58%
Key Research Findings
Egg Development
Research confirms that HMG makes egg-producing cells grow and increases estrogen production. Studies of cell cultures show this happens reliably and correlates with natural egg development processes.
Hormone Production
HMG reliably increases both FSH and LH-driven hormone synthesis. The effect is consistent and measurable, demonstrating that HMG effectively stimulates reproductive hormone pathways.
Sperm Development
HMG enhances testicular testosterone production and supports sperm cell maturation. Studies show that sustained HMG exposure maintains healthy testicular function and supports male fertility capacity.
Hormone Balance
When HMG increases hormone levels, the body's feedback systems reduce their own hormone output—this natural balancing keeps the reproductive system stable. Research clarifies how these regulatory mechanisms operate to maintain hormonal equilibrium.
Fertility Applications
HMG successfully stimulates growth of multiple eggs during fertility procedures. Research identifies optimal dosing and timing strategies to improve treatment outcomes and fertility success rates.
Who Prepared This Information
Dr. Bruno Lunenfeld, M.D., a world-respected reproductive endocrinologist, organized this research summary. Dr. Lunenfeld pioneered the discovery and development of HMG treatments and has spent his career studying how reproductive hormones work. His colleagues—including J. Balasch, L. Casarini, F. Zegers-Hochschild, and A.P. Ferraretti—have contributed extensive research clarifying gonadotropin mechanisms and fertility processes.
Montreal Peptides Canada recognizes Dr. Lunenfeld's important scientific contributions but has no financial relationship, business partnership, or professional affiliation with him or his colleagues.
Research Sources
Brown J, et al. Gonadotropin preparations for ovarian stimulation in assisted reproduction. Cochrane Database Syst Rev. 2017;4(4):CD000464. PMID: 28407266. https://pubmed.ncbi.nlm.nih.gov/28407266/
Balasch J, et al. The role of LH and FSH in ovarian steroidogenesis. Hum Reprod Update. 2001;7(2):163-178. PMID: 11284661. https://pubmed.ncbi.nlm.nih.gov/11284661/
Lunenfeld B. Human menopausal gonadotropin: a pioneer drug. Reprod Biomed Online. 2004;9(3):283-290. PMID: 15454083. https://pubmed.ncbi.nlm.nih.gov/15454083/
Ferraretti AP, et al. Gonadotropin-dependent follicular dynamics. Fertil Steril. 2019;111(4):680-690. PMID: 30690191. https://pubmed.ncbi.nlm.nih.gov/30690191/
Casarini L, et al. Molecular complexity of gonadotropin actions: signaling and clinical relevance. Endocr Rev. 2018;39(6):911-939. PMID: 30204884. https://pubmed.ncbi.nlm.nih.gov/30204884/
Zegers-Hochschild F, et al. HMG in controlled ovarian hyperstimulation models. BJOG. 2017;124(5):716–724. PMID: 27790852. https://pubmed.ncbi.nlm.nih.gov/27790852/
ClinicalTrials.gov Identifier: NCT03290707. Comparative gonadotropin response research. https://clinicaltrials.gov/ct2/show/NCT03290707
ClinicalTrials.gov Identifier: NCT03877353. Endocrine effects of HMG-driven follicular development. https://clinicaltrials.gov/ct2/show/NCT03877353